Annual CFF
$17.18 M
-$17.83 M-50.93%
December 31, 2022
Summary
- As of February 10, 2025, BXRX annual cash flow from financing activities is $17.18 million, with the most recent change of -$17.83 million (-50.93%) on December 31, 2022.
- During the last 3 years, BXRX annual CFF has fallen by -$52.09 million (-75.20%).
Performance
BXRX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$1.38 M
+$464.00 K+50.60%
September 1, 2023
Summary
- As of February 10, 2025, BXRX quarterly cash flow from financing activities is $1.38 million, with the most recent change of +$464.00 thousand (+50.60%) on September 1, 2023.
- Over the past year, BXRX quarterly CFF has dropped by -$2.94 million (-68.07%).
Performance
BXRX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$8.90 M
-$2.94 M-24.85%
September 1, 2023
Summary
- As of February 10, 2025, BXRX TTM cash flow from financing activities is $8.90 million, with the most recent change of -$2.94 million (-24.85%) on September 1, 2023.
- Over the past year, BXRX TTM CFF has dropped by -$8.63 million (-49.22%).
Performance
BXRX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BXRX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -50.9% | -68.1% | -49.2% |
| 3 y3 years | -75.2% | +151.3% | -85.6% |
| 5 y5 years | -61.4% | - | -87.2% |
BXRX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.9% | at low | -83.9% | -34.7% | -74.6% | at low |
| 5 y | 5-year | -75.2% | at low | -94.9% | -294.8% | -89.1% | at low |
| alltime | all time | -75.2% | at low | -94.9% | -294.8% | -89.1% | at low |
Baudax Bio Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $1.38 M(+50.6%) | $8.90 M(-24.9%) |
| Jun 2023 | - | $917.00 K(-71.4%) | $11.85 M(+0.1%) |
| Mar 2023 | - | $3.21 M(-5.5%) | $11.83 M(-31.1%) |
| Dec 2022 | $17.18 M(-50.9%) | $3.40 M(-21.5%) | $17.18 M(-2.0%) |
| Sep 2022 | - | $4.33 M(+379.5%) | $17.53 M(+33.5%) |
| Jun 2022 | - | $902.00 K(-89.5%) | $13.13 M(-39.4%) |
| Mar 2022 | - | $8.56 M(+128.7%) | $21.65 M(-38.2%) |
| Dec 2021 | $35.01 M | $3.74 M(-4897.4%) | $35.01 M(-32.6%) |
| Sep 2021 | - | -$78.00 K(-100.8%) | $51.97 M(+5.3%) |
| Jun 2021 | - | $9.43 M(-57.0%) | $49.36 M(-5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $21.92 M(+5.9%) | $52.36 M(-8.6%) |
| Dec 2020 | $57.30 M(-17.3%) | $20.70 M(-869.4%) | $57.30 M(-7.5%) |
| Sep 2020 | - | -$2.69 M(-121.6%) | $61.97 M(-8.4%) |
| Jun 2020 | - | $12.43 M(-53.7%) | $67.68 M(-16.8%) |
| Mar 2020 | - | $26.86 M(+5.9%) | $81.30 M(+17.4%) |
| Dec 2019 | $69.27 M(+9.6%) | $25.37 M(+738.0%) | $69.27 M(+57.8%) |
| Sep 2019 | - | $3.03 M(-88.4%) | $43.90 M(+7.4%) |
| Jun 2019 | - | $26.05 M(+75.8%) | $40.88 M(+175.8%) |
| Mar 2019 | - | $14.82 M | $14.82 M |
| Dec 2018 | $63.20 M(+41.8%) | - | - |
| Dec 2017 | $44.56 M | - | - |
FAQ
- What is Baudax Bio annual cash flow from financing activities?
- What is the all time high annual CFF for Baudax Bio?
- What is Baudax Bio annual CFF year-on-year change?
- What is Baudax Bio quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Baudax Bio?
- What is Baudax Bio quarterly CFF year-on-year change?
- What is Baudax Bio TTM cash flow from financing activities?
- What is the all time high TTM CFF for Baudax Bio?
- What is Baudax Bio TTM CFF year-on-year change?
What is Baudax Bio annual cash flow from financing activities?
The current annual CFF of BXRX is $17.18 M
What is the all time high annual CFF for Baudax Bio?
Baudax Bio all-time high annual cash flow from financing activities is $69.27 M
What is Baudax Bio annual CFF year-on-year change?
Over the past year, BXRX annual cash flow from financing activities has changed by -$17.83 M (-50.93%)
What is Baudax Bio quarterly cash flow from financing activities?
The current quarterly CFF of BXRX is $1.38 M
What is the all time high quarterly CFF for Baudax Bio?
Baudax Bio all-time high quarterly cash flow from financing activities is $26.86 M
What is Baudax Bio quarterly CFF year-on-year change?
Over the past year, BXRX quarterly cash flow from financing activities has changed by -$2.94 M (-68.07%)
What is Baudax Bio TTM cash flow from financing activities?
The current TTM CFF of BXRX is $8.90 M
What is the all time high TTM CFF for Baudax Bio?
Baudax Bio all-time high TTM cash flow from financing activities is $81.30 M
What is Baudax Bio TTM CFF year-on-year change?
Over the past year, BXRX TTM cash flow from financing activities has changed by -$8.63 M (-49.22%)